Develops next-generation allogeneic cell therapies with switchable targeting for hard-to-treat blood cancers like AML.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
AvenCell derives its name from the French word ‘avenir’ to reflect the aim to be the FUTURE of cell therapy. AvenCell is building a truly transformative cell therapy company that targets difficult-to-treat cancers, with its lead programs focusing on acute myeloid leukemia (AML) and additional programs targeting other hematological malignancies. AvenCell was formed with the goal to create truly allogeneic cells that persist as long or longer than autologous therapies and develop a universal and switchable construct that allows complete control and target redirection of T cells after they are infused into a patient. Integration of these two platforms allows for complete separation of the manufacturing of cells from ultimate patient and cancer target, thus providing significant scalability potential at orders of magnitude more efficient than current approaches.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
AvenCell Therapeutics Management Team
Investors
Blackstone Life Sciences
Eight Roads Ventures Japan
F-Prime
Novo Holdings
NYBC Ventures
Piper Heartland Healthcare Capital
AvenCell Therapeutics Valuations & Financials
View real-time NPM data on AvenCell Therapeutics stock including daily AvenCell Therapeutics stock price estimates, valuation history, and historical share price information. Access AvenCell Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track AvenCell Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on AvenCell Therapeutics? Get in touch to learn more.
Similar Companies
like AvenCell Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Mitra Bio
Healthcare & Life Sciences
Offers non-invasive skin diagnostics analyzing DNA methylation to assess skin health and aging.
CropX
Climate & Sustainability
Delivers integrated hardware and software to optimize farm productivity through real-time soil, crop, and irrigation data insights.
Fabletics
Consumer
Online and retail brand that offers affordable sportswear, footwear, and accessories for men and women.
Syrup Tech
Commerce & Marketplaces
Predicts demand and guides inventory decisions with intelligent, data‑driven recommendations.
Botanical Solution
Healthcare & Life Sciences
Cultivates botanical materials via tissue culture that supply sustainable agricultural and pharmaceutical inputs.
Kuaishou
Climate & Sustainability
Refines oil into fuels, petrochemical goods, and related services for industrial and consumer use.
Zap Energy
Climate & Sustainability
Harnesses self-pinching plasma for compact, magnet-free fusion energy.
Simon Data
Enterprise Software
Delivers AI-powered personalized marketing by combining customer data with real-world signals for automated, adaptive campaigns at scale.
FAQ
We have answers
AvenCell Therapeutics stock does not trade on public stock exchanges. AvenCell Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in AvenCell Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
AvenCell Therapeutics Stock does not trade on public stock exchanges. In order to sell AvenCell Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
AvenCell Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view AvenCell Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for AvenCell Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell AvenCell Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in AvenCell Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
AvenCell Therapeutics is a private company and has not had an IPO. There is currently no AvenCell Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to AvenCell Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
